80/100B160.420
USD
-2.88
(-1.76%)
Pre Open
Last updated: · Delayed 15 min
Fair value128.72Plus+25%103Price 160.42634
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Q4 FY2026 · Earnings report
EPS estimate 2.23Revenue estimate 14.65B
Novartis EPS (earnings per share) 1998–2026What is EPS (earnings per share)? EPS (earnings per share) is a company's net income divided by its number of shares: the profit that belongs to each share over a period.
Novartis's diluted EPS in Q3 FY2026, the three months to 30 September 2026, was 0.63 USD, down 68.8% on the same quarter a year before. Novartis's diluted earnings per share over the last twelve months were 5.24 USD, down 28.3% on the twelve months before. In fiscal year 2025 they were 7.19 USD, up 22.5% on the year before.
Last updated 8 Nov 2026 · Next report 3 Feb 2027
EPS
Growth
| Fiscal year | Period ending | EPS | Growth | EPS (basic) |
|---|---|---|---|---|
| TTM | 30 Sept 2026 | 5.24 | -28.32% | 5.25 |
| FY2025 | 31 Dec 2025 | 7.19 | +22.49% | 7.25 |
| FY2024 | 31 Dec 2024 | 5.87 | -17.32% | 5.92 |
| FY2023 | 31 Dec 2023 | 7.10 | +123.97% | 7.15 |
| FY2022 | 31 Dec 2022 | 3.17 | -70.18% | 3.19 |
| FY2021 | 31 Dec 2021 | 10.63 | +201.99% | 10.71 |
| FY2020 | 31 Dec 2020 | 3.52 | +14.29% | 3.54 |
| FY2019 | 31 Dec 2019 | 3.08 | -42.75% | 3.12 |
| FY2018 | 31 Dec 2018 | 5.38 | +65.54% | 5.44 |
| FY2017 | 31 Dec 2017 | 3.25 | +16.07% | 3.28 |
| FY2016 | 31 Dec 2016 | 2.80 | -61.59% | 2.82 |
| FY2015 | 31 Dec 2015 | 7.29 | +76.51% | 7.40 |
| FY2014 | 31 Dec 2014 | 4.13 | +11.62% | 4.21 |
| FY2013 | 31 Dec 2013 | 3.70 | -4.88% | 3.76 |
| FY2012 | 31 Dec 2012 | 3.89 | +5.14% | 3.93 |
| FY2011 | 31 Dec 2011 | 3.70 | -13.15% | 3.75 |
| FY2010 | 31 Dec 2010 | 4.26 | +15.45% | 4.28 |
| FY2009 | 31 Dec 2009 | 3.69 | +2.79% | 3.70 |
| FY2008 | 31 Dec 2008 | 3.59 | -30.02% | 3.62 |
| FY2007 | 31 Dec 2007 | 5.13 | +68.75% | 5.15 |
| FY2006 | 31 Dec 2006 | 3.04 | +16.03% | 3.06 |
| FY2005 | 31 Dec 2005 | 2.62 | +15.42% | 2.63 |
| FY2004 | 31 Dec 2004 | 2.27 | +15.23% | 2.28 |
| FY2003 | 31 Dec 2003 | 1.97 | +7.07% | 1.99 |
| FY2002 | 31 Dec 2002 | 1.84 | +23.49% | 1.88 |
| FY2001 | 31 Dec 2001 | 1.49 | -12.35% | 1.49 |
| FY2000 | 31 Dec 2000 | 1.70 | +174.19% | 1.70 |
| FY1999 | 31 Dec 1999 | 0.62 | +87.88% | 0.62 |
| FY1998 | 31 Dec 1998 | 0.33 | — | 0.33 |
| Quarter | Period ending | EPS | Growth on a year before | EPS (basic) |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.63 | -68.81% | 0.63 |
| Q2 FY2026 | 30 Jun 2026 | 1.71 | -16.99% | 1.71 |
| Q1 FY2026 | 31 Mar 2026 | 1.65 | -9.34% | 1.65 |
| Q4 FY2025 | 31 Dec 2025 | 1.25 | -11.35% | 1.26 |
| Q3 FY2025 | 29 Sept 2025 | 2.02 | +28.66% | 2.04 |
| Q2 FY2025 | 30 Jun 2025 | 2.06 | +29.56% | 2.07 |
| Q1 FY2025 | 31 Mar 2025 | 1.82 | +38.93% | 1.83 |
| Q4 FY2024 | 31 Dec 2024 | 1.41 | -65.69% | 1.42 |
| Q3 FY2024 | 30 Sept 2024 | 1.57 | +84.71% | 1.58 |
| Q2 FY2024 | 30 Jun 2024 | 1.59 | +43.24% | 1.60 |
| Q1 FY2024 | 31 Mar 2024 | 1.31 | +21.30% | 1.32 |
| Q4 FY2023 | 31 Dec 2023 | 4.11 | +504.41% | 4.14 |
| Q3 FY2023 | 30 Sept 2023 | 0.85 | +18.06% | 0.85 |
| Q2 FY2023 | 30 Jun 2023 | 1.11 | +44.16% | 1.11 |
| Q1 FY2023 | 31 Mar 2023 | 1.08 | +9.09% | 1.09 |
| Q4 FY2022 | 31 Dec 2022 | 0.68 | -90.61% | 0.69 |
| Q3 FY2022 | 30 Sept 2022 | 0.72 | -40.98% | 0.73 |
| Q2 FY2022 | 30 Jun 2022 | 0.77 | -39.84% | 0.77 |
| Q1 FY2022 | 31 Mar 2022 | 0.99 | +8.79% | 1.00 |
| Q4 FY2021 | 31 Dec 2021 | 7.24 | +686.96% | 7.29 |
| Q3 FY2021 | 30 Sept 2021 | 1.22 | +45.24% | 1.23 |
| Q2 FY2021 | 30 Jun 2021 | 1.28 | +58.02% | 1.29 |
| Q1 FY2021 | 31 Mar 2021 | 0.91 | -4.21% | 0.91 |
| Q4 FY2020 | 31 Dec 2020 | 0.92 | +87.76% | 0.92 |
| Q3 FY2020 | 30 Sept 2020 | 0.84 | -5.62% | 0.85 |
| Q2 FY2020 | 30 Jun 2020 | 0.81 | -72.16% | 0.82 |
| Q1 FY2020 | 31 Mar 2020 | 0.95 | +25.00% | 0.96 |
| Q4 FY2019 | 31 Dec 2019 | 0.49 | -5.77% | 0.50 |
| Q3 FY2019 | 30 Sept 2019 | 0.89 | +28.99% | 0.90 |
| Q2 FY2019 | 30 Jun 2019 | 2.91 | -12.08% | 2.94 |
| Q1 FY2019 | 31 Mar 2019 | 0.76 | -11.63% | 0.77 |
| Q4 FY2018 | 31 Dec 2018 | 0.52 | -38.10% | 0.52 |
| Q3 FY2018 | 30 Sept 2018 | 0.69 | -21.59% | 0.70 |
| Q2 FY2018 | 30 Jun 2018 | 3.31 | +298.80% | 3.34 |
| Q1 FY2018 | 31 Mar 2018 | 0.86 | +22.86% | 0.87 |
| Q4 FY2017 | 31 Dec 2017 | 0.84 | +110.00% | 0.85 |
| Q3 FY2017 | 30 Sept 2017 | 0.88 | +8.64% | 0.89 |
| Q2 FY2017 | 30 Jun 2017 | 0.83 | +10.67% | 0.84 |
| Q1 FY2017 | 31 Mar 2017 | 0.70 | -16.67% | 0.70 |
| Q4 FY2016 | 31 Dec 2016 | 0.40 | -9.09% | 0.40 |
| Q3 FY2016 | 30 Sept 2016 | 0.81 | +5.19% | 0.81 |
| Q2 FY2016 | 30 Jun 2016 | 0.75 | 0.00% | 0.76 |
| Q1 FY2016 | 31 Mar 2016 | 0.84 | -84.21% | 0.85 |
| Q4 FY2015 | 31 Dec 2015 | 0.44 | -27.87% | 0.44 |
| Q3 FY2015 | 30 Sept 2015 | 0.77 | -41.22% | 0.79 |
| Q2 FY2015 | 30 Jun 2015 | 0.75 | -27.18% | 0.76 |
| Q1 FY2015 | 31 Mar 2015 | 5.32 | +347.06% | 5.40 |
| Q4 FY2014 | 31 Dec 2014 | 0.61 | -25.61% | 0.62 |
| Q3 FY2014 | 30 Sept 2014 | 1.31 | +45.56% | 1.33 |
| Q2 FY2014 | 30 Jun 2014 | 1.03 | +1.98% | 1.05 |
| Q1 FY2014 | 31 Mar 2014 | 1.19 | +22.68% | 1.21 |
| Q4 FY2013 | 31 Dec 2013 | 0.82 | -1.20% | 0.83 |
| Q3 FY2013 | 30 Sept 2013 | 0.90 | -8.16% | 0.91 |
| Q2 FY2013 | 30 Jun 2013 | 1.01 | -7.34% | 1.03 |
| Q1 FY2013 | 31 Mar 2013 | 0.97 | +5.43% | 0.98 |
| Q4 FY2012 | 31 Dec 2012 | 0.83 | +72.92% | 0.84 |
| Q3 FY2012 | 30 Sept 2012 | 0.98 | -2.97% | 0.99 |
| Q2 FY2012 | 30 Jun 2012 | 1.09 | -1.80% | 1.09 |
| Q1 FY2012 | 31 Mar 2012 | 0.92 | -23.33% | 0.93 |
| Q4 FY2011 | 31 Dec 2011 | 0.48 | -49.47% | 0.48 |
| Q3 FY2011 | 30 Sept 2011 | 1.01 | +2.02% | 1.02 |
| Q2 FY2011 | 30 Jun 2011 | 1.11 | +5.71% | 1.13 |
| Q1 FY2011 | 31 Mar 2011 | 1.20 | -6.25% | 1.21 |
| Q4 FY2010 | 31 Dec 2010 | 0.95 | -6.86% | 0.95 |
| Q3 FY2010 | 30 Sept 2010 | 0.99 | +7.61% | 0.99 |
| Q2 FY2010 | 30 Jun 2010 | 1.05 | +17.98% | 1.06 |
| Q1 FY2010 | 31 Mar 2010 | 1.28 | +48.84% | 1.29 |
| Q4 FY2009 | 31 Dec 2009 | 1.02 | +50.00% | 1.02 |
| Q3 FY2009 | 30 Sept 2009 | 0.92 | 0.00% | 0.93 |
| Q2 FY2009 | 30 Jun 2009 | 0.89 | -9.18% | 0.90 |
| Q1 FY2009 | 31 Mar 2009 | 0.86 | -15.69% | 0.87 |
| Q4 FY2008 | 31 Dec 2008 | 0.68 | +74.36% | 0.68 |
| Q3 FY2008 | 30 Sept 2008 | 0.92 | -68.92% | 0.92 |
| Q2 FY2008 | 30 Jun 2008 | 0.98 | +15.29% | 0.99 |
| Q1 FY2008 | 31 Mar 2008 | 1.02 | +9.68% | 1.02 |
| Q4 FY2007 | 31 Dec 2007 | 0.39 | -44.29% | 0.39 |
| Q3 FY2007 | 30 Sept 2007 | 2.96 | +260.98% | 2.97 |
| Q2 FY2007 | 30 Jun 2007 | 0.85 | +18.06% | 0.86 |
| Q1 FY2007 | 31 Mar 2007 | 0.93 | +12.05% | 0.93 |
| Q4 FY2006 | 31 Dec 2006 | 0.70 | +20.69% | 0.70 |
| Q3 FY2006 | 30 Sept 2006 | 0.82 | +15.49% | 0.83 |
| Q2 FY2006 | 30 Jun 2006 | 0.72 | +33.33% | 0.73 |
| Q1 FY2006 | 31 Mar 2006 | 0.83 | +31.75% | 0.83 |
| Q4 FY2005 | 31 Dec 2005 | 0.58 | +3.57% | 0.58 |
| Q3 FY2005 | 30 Sept 2005 | 0.71 | +12.70% | 0.71 |
| Q2 FY2005 | 30 Jun 2005 | 0.54 | -14.29% | 0.54 |
| Q1 FY2005 | 31 Mar 2005 | 0.63 | +21.15% | 0.63 |
| Q4 FY2004 | 31 Dec 2004 | 0.56 | +1.82% | 0.56 |
| Q3 FY2004 | 30 Sept 2004 | 0.63 | +23.53% | 0.63 |
| Q2 FY2004 | 30 Jun 2004 | 0.63 | +21.15% | 0.63 |
| Q1 FY2004 | 31 Mar 2004 | 0.52 | +23.81% | 0.52 |
| Q4 FY2003 | 31 Dec 2003 | 0.55 | -16.67% | 0.55 |
| Q3 FY2003 | 30 Sept 2003 | 0.51 | +30.77% | 0.52 |
| Q2 FY2003 | 30 Jun 2003 | 0.52 | -5.45% | 0.53 |
| Q1 FY2003 | 31 Mar 2003 | 0.42 | -2.33% | 0.43 |
| Q4 FY2002 | 31 Dec 2002 | 0.66 | +65.00% | 0.66 |
| Q3 FY2002 | 30 Sept 2002 | 0.39 | -11.36% | 0.39 |
| Q2 FY2002 | 30 Jun 2002 | 0.55 | +37.50% | 0.55 |
| Q1 FY2002 | 31 Mar 2002 | 0.43 | +4.88% | 0.43 |
| Q4 FY2001 | 31 Dec 2001 | 0.40 | -2.44% | 0.40 |
| Q3 FY2001 | 30 Sept 2001 | 0.44 | +33.33% | 0.44 |
| Q2 FY2001 | 30 Jun 2001 | 0.40 | 0.00% | 0.40 |
| Q1 FY2001 | 31 Mar 2001 | 0.41 | -16.33% | 0.41 |
| Q4 FY2000 | 31 Dec 2000 | 0.41 | — | 0.41 |
| Q3 FY2000 | 30 Sept 2000 | 0.33 | — | 0.33 |
| Q2 FY2000 | 30 Jun 2000 | 0.40 | — | 0.40 |
| Q1 FY2000 | 31 Mar 2000 | 0.49 | — | 0.49 |
Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
See also:Revenue,Net income,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Novartis's EPS
Source: Financial Modeling Prep